Brain-Computer Interface

Researchers have developed an AI to diagnose up to 10 types of dementia, helping discuss cybernetic implants for dementia treatments.

The FDA has approved Neuralink’s experimental brain chip for a second human patient after the team proposed a fix to the electrode’s retreat.

Neuralink went ahead with its human trials, fully knowing that the neurochip’s wires retracted, according to Reuters.

Neuralink’s PRIME study faces a setback as Noland Arbaugh's first in-human brain implant exhibits mechanical issues.